Funds › Glenview Capital Management, LLC
Glenview Capital Management, LLC
13F for Q3 2026, filed Nov 16, 2026. 135 positions worth $6.1B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
$6.1B+$637.2M (11.6%) vs Q2 2026Q3 2026 · filed Nov 16
Latest report
Q3 2026
filed Nov 16, 2026
Reported value
$6.1B
+$637.2M (11.6%) vs Q2 2026
Positions
135
42 in Q2 2026
Top 10 share
55.1%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | GPN Global Payments Inc. | 7.11M | $580.3M | 9.5% | -20.2% | 13F ↗ |
| 2 | THC Tenet Healthcare Corporation | 2.05M | $523.3M | 8.5% | -8.4% | 13F ↗ |
| 3 | AMZN Amazon.com, Inc. | 1.50M | $372.6M | 6.1% | +17.6% | 13F ↗ |
| 4 | META Meta Platforms, Inc. | 495,268 | $359.2M | 5.9% | +38.8% | 13F ↗ |
| 5 | TMO Thermo Fisher Scientific Inc | 444,245 | $299.9M | 4.9% | -29.2% | 13F ↗ |
| 6 | TEVA Teva Pharmaceutical Industries Limited | 7.57M | $299.6M | 4.9% | New | 13F ↗ |
| 7 | A Agilent Technologies, Inc. | 1.49M | $257.5M | 4.2% | -24.1% | 13F ↗ |
| 8 | AMD Advanced Micro Devices, Inc. | 391,267 | $239.4M | 3.9% | +31.1% | 13F ↗ |
| 9 | DHR Danaher Corporation | 1.06M | $234.3M | 3.8% | -7.7% | 13F ↗ |
| 10 | HUM Humana Inc. | 545,385 | $208.1M | 3.4% | +115% | 13F ↗ |
| 11 | ONTO Onto Innovation Inc. | 585,039 | $180.1M | 2.9% | +184% | 13F ↗ |
| 12 | CNC Centene Corporation | 2.36M | $146.9M | 2.4% | +25.4% | 13F ↗ |
| 13 | UBER Uber Technologies, Inc. | 2.09M | $142.9M | 2.3% | +16.3% | 13F ↗ |
| 14 | CI The Cigna Group | 463,052 | $125.9M | 2.1% | +12.3% | 13F ↗ |
| 15 | CVS CVS Health Corporation | 1.28M | $109.6M | 1.8% | -73.5% | 13F ↗ |
| 16 | BFLY Butterfly Network, Inc. | 11.84M | $106.1M | 1.7% | -17.4% | 13F ↗ |
| 17 | GENI Genius Sports Limited | 16.62M | $95.2M | 1.6% | +23.2% | 13F ↗ |
| 18 | UAL United Airlines Holdings, Inc. | 822,254 | $91.2M | 1.5% | +66.2% | 13F ↗ |
| 19 | SGRY Surgery Partners, Inc. | 6.52M | $90.4M | 1.5% | New | 13F ↗ |
| 20 | BRKR Bruker Corporation | 1.38M | $89.2M | 1.5% | +446% | 13F ↗ |
| 21 | MRVL Marvell Technology, Inc. | 312,045 | $82.4M | 1.3% | New | 13F ↗ |
| 22 | CSCO Cisco Systems, Inc. | 703,960 | $75.8M | 1.2% | +70.3% | 13F ↗ |
| 23 | ORCL Oracle Corporation | 538,519 | $73.9M | 1.2% | New | 13F ↗ |
| 24 | XYZ Block, Inc. | 944,920 | $69.5M | 1.1% | -21.1% | 13F ↗ |
| 25 | LLY Eli Lilly and Company | 57,771 | $66.8M | 1.1% | Unchanged | 13F ↗ |
| 26 | ESI Element Solutions Inc. | 1.63M | $59.0M | 1.0% | +63.6% | 13F ↗ |
| 27 | AMAT Applied Materials, Inc. | 113,745 | $58.2M | 0.9% | +74.5% | 13F ↗ |
| 28 | MKSI MKS Inc. | 169,476 | $45.0M | 0.7% | +72.0% | 13F ↗ |
| 29 | EYE National Vision Holdings, Inc. | 2.60M | $42.6M | 0.7% | -16.1% | 13F ↗ |
| 30 | TXN Texas Instruments Incorporated | 142,465 | $39.9M | 0.7% | New | 13F ↗ |
| 31 | RRX Regal Rexnord Corporation | 223,722 | $34.7M | 0.6% | New | 13F ↗ |
| 32 | ABBV AbbVie Inc. | 124,770 | $32.6M | 0.5% | -16.2% | 13F ↗ |
| 33 | TSM Taiwan Semiconductor Manufacturing Company Ltd. | 71,104 | $32.4M | 0.5% | New | 13F ↗ |
| 34 | APO Apollo Global Management, Inc. | 275,781 | $32.0M | 0.5% | New | 13F ↗ |
| 35 | BLCO Bausch + Lomb Corporation | 1.88M | $32.0M | 0.5% | -2.0% | 13F ↗ |
| 36 | DOCN DigitalOcean Holdings, Inc. | 213,645 | $28.5M | 0.5% | +152% | 13F ↗ |
| 37 | NCLH Norwegian Cruise Line Holdings Ltd. | 1.74M | $25.6M | 0.4% | New | 13F ↗ |
| 38 | QCOM QUALCOMM Incorporated | 138,134 | $25.4M | 0.4% | New | 13F ↗ |
| 39 | CORZ Core Scientific, Inc. | 1.59M | $25.4M | 0.4% | New | 13F ↗ |
| 40 | USFD US Foods Holding Corp. | 251,516 | $23.2M | 0.4% | New | 13F ↗ |
| 41 | AZN AstraZeneca PLC | 125,678 | $20.3M | 0.3% | -31.8% | 13F ↗ |
| 42 | BIIB Biogen Inc. | 68,169 | $15.4M | 0.3% | New | 13F ↗ |
| 43 | AGIO Agios Pharmaceuticals, Inc. | 459,792 | $15.3M | 0.2% | New | 13F ↗ |
| 44 | BKNG Booking Holdings Inc. | 80,021 | $13.0M | 0.2% | New | 13F ↗ |
| 45 | OWL Blue Owl Capital Inc. | 1.42M | $12.9M | 0.2% | New | 13F ↗ |
| 46 | NVS Novartis AG · ADR | 86,909 | $12.4M | 0.2% | Unchanged | 13F ↗ |
| 47 | VTRS Viatris Inc. | 209,983 | $3.7M | 0.1% | -97.9% | 13F ↗ |
| 48 | BSX Boston Scientific Corporation | 70,348 | $3.1M | 0.1% | -37.8% | 13F ↗ |
| 49 | TECH Bio-Techne Corp | 35,839 | $2.6M | <0.1% | -38.6% | 13F ↗ |
| 50 | VEEV Veeva Systems Inc. | 8,400 | $2.4M | <0.1% | New | 13F ↗ |
Showing the top 50 of 135 positions. Premium lists every position, plus puts and calls.
Ten largest positions
By value, Q3 2026.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer